Infectious Diseases Flashcards

1
Q

Routes of Transmission

HEP B

A

Vertical
Horizontal
–> Sexual (very common- more infectious than HIV or HCV)
–> Blood transfusion and procedures (dialysis/ operations)
–> Needles or sharps- re-use or injury
–> Household transmission - use of shared razors or toothbrushes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Etiological agent of Hep B

A

enveloped DNA virus of hepadnaviridae family

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Antigens of Hep B

A
  • surface antigen (HBsAg)
  • envelope antigen (HBeAg)
  • core antigen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

HBsAG (hep b surface antigen)

A

protein found in blood or serum of patients with current infection

  • used as diagnostic confirmation of infection
  • genetically producable –> used a vaccine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

HBeAg (Envelope antigen)

A

allows for assessment of phase of infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

HBsAb (surface antibody)

A

indicates immunity to hep B following immunisation or infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HBeAB (envelope antibody)

A

appears in the later phase of the disease in acute and chronic infection

evidence of immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

HBcAb (core antibody)

A

found in most people exposed to HBV
- tested as total (IgG and IgM)
- doesn’t discriminate between acute/chronic/past infections
- not found after immunisation
IgM routine test on new diagnosis - identifies acute infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

HBV DNA

A

measured and quantified by nucleic acid testing like PCR

- determines grade of replication and activity of the virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Acute or Chronic?

Hep B

A

host characteristics determines if the virus is cleared within 6 months - age, immune status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Acute hep B management

A

usually self limiting
no indication for treatment
occasionally fulminant hepatitis can cause liver failure (indicated by rising INR) –> requires a liver transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Chronic Hep B

A
  • lasting longer than 6 months
  • if acquired at birth may last decades (90% of cases chronic)
  • 5% of adults with Hep B have chronic disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Chronic Hep B

Prevention

A

immunisation
immunoglobulin post exposure administration
- both used in highly infectious mothers at the end of pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hep B diagnosis

A

usually asymptomatic

serological testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Chronic Hep B complications

A

cirrhosis
hepatocellular carcinoma
considered an oncogenic virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Chronic Hep B management

A
  • identifying phase of the infection
  • control viral replication
  • reduce inflammation
  • pegylated interferon alpha (weekly injections 48/52)
  • ## Tenofovir or Entecavir daily (long term)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Hep C

A

hepacivirus from Flaviviridae family
160,000 chronically infected in the UK
3rd largest cause of end stage liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Hep C modes of transmission

A
  • parenteral
  • common in former IVDUs
  • small number of pts from infected transfusions
  • needle stick injuries and tattooing
  • low risk of household transmission unless sharing razors or toothbrushes
  • sexual transmission is rare
  • vertical transmission in 6% of positive mothers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Response to infection

Hep C

A
  • most asymptomatic or symptoms that require medical attention
  • 15% - malaise, nausea, RUQ pain and jaundice
  • if symptomatic more likely to clear the disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Symptoms of Chronic Hep C

A
non-specific 
usually asymptomatic but may have:
- malaise
- fatigue 
- intermittent RUQpain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Extra-hepatic manifestations of Hep C

common associations

A
  • essential mixed cryoglobulinaemia (abnormal proteins in blood that clump together in cold temps)
  • membranoproliferative glomerulonephritis
  • porphyria cutanea tarda (photosensitivity)
  • autoimmune thyroid disease (women)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Extra-hepatic manifestations of Hep C

rare associations

A
  • lichen planus
  • Sjogren’s syndrome
  • B-cell lymphoma
  • interstitial lung disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Diagnosis of Hep C

A

primarily serological
enzyme immunoassay followed by confirmatory testing with an immunoblot assay
positive serology –> HCV RNA testing with PCR to confirm current infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

HCV genotypes

A

6 with different geological distributions
most common in the UK are genotypes 1 & 2/3
Genotype 4 common in Africa/ Middle East
Genotype 5 common in South Africa
Genotype 6 common in SE Asia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Hep C and ESLD
chronic infection --> 1/3 chance of ESLD in 25 years further 1/3 will develop ESLD after 25 years - risk increased/ accelarated by : HIV African- Americans
26
Clinical Assessment of Hep C
Fibro-scan for fibrosis baseline Potentially need a liver biopsy advanced fibrosis (Metavir F3) or cirrhosis (Metavir F4) --> screening for HCC 6/12 AFP (alpha fetoprotein) and liver USS
27
Treatment of Hep C
Aim is curative (undetectable HCV RNA 12/52 after finishing treatment) - direct acting anti-retroviral drugs - higher cure rates, shorter treatment durations and less side affects than pegylated interferon alpha and ribavarin dual therapy
28
Direct Acting Anti-Retrovirals
- act on specific HCV enzymes, analogous to ART for HIV - NS3/4A protease inhibitors (-previr) (CI in decompensated cirrhosis) - NS5A inhibitors (-asvir) - NS5B inhibitors (buvir) combination of 2 agents
29
Re-Treatment regime for Hep C
``` 3 agents (CI in decompensated cirrhosis) Sofosbuvir/ Velpatasvir and ribavirin (funded for pts with decompensated cirrhosis) ```
30
What causes infectious mononucleosis? | glandular fever
Epstein- Barr spread by saliva or droplets
31
EBV- demographics
- early childhood few symptoms - adolescents/ young adults - infectious mononucleosis - associated with cancers - stomach/nasal/lymphoma
32
EBV facts
- DNA herpesvirus - predilection for B-lymphocytes and causes - causes proliferation of T-cells which are cytotoxic to EBV, can proliferate like immunoblastic lymphoma
33
Signs and Symptoms of EBV
- sore throat, temp, anorexia, malaise, lymphadenopathy, palatal petechiae, splenomegaly, fatigue, low mood
34
severe chronic active EBV infection
- anaemia - low platelets - hepatosplenomegaly - fatigue
35
Severe complications of EBV
``` meningoencephalitis cerebellitis Guillan- Barré myeloradiculitis cranial nerve lesions fulminant hepatitis RDS (respiratory distress syndrome) severe thrombocytopeania/ aplastic anaemia acute renal failure Myocarditis ```
36
EBV Blood Film
lymphocytosis | atypical lymphocytes - large irregular nuclei
37
Differential Diagnosis for EBV
``` Streptococci CMV Viral hepatitis HIV seroconversion Toxoplasmosis Leukaemia DIptheria ```
38
Management of EBV
none manage chronic fatigue- avoid vigorous sports - splenic rupture Steroids +/- aciclovir for severe symptoms
39
EBV oncogenicity
Lymphoma Nasopharyngeal cancer Leiomyosarcoma Oral hairy leucoplakia
40
CMV
Direct transmission Becomes latent after acute infection but may reactivate at times of stress or immunocompromise may be indistinguishable from glandular fever or acute hepatitis
41
CMV post transplant
fever> pneumonitis> colitis> hepatitis> retinitis
42
CMV &HIV
retinitis> colitis >CNS disease
43
CMV diagnosis
IgM acute infection (unreliable if HIV +ve) | CMV PCR of blood/CSF/ bronchoalveolar lavage
44
CMV treatment
only if serious infection | - ganciclovir IV or valganciclovir, foscarnet, cidofovir
45
Post-transplant prevention for CMV
- weekly PCR 14/52 | - treat if positive
46
Congenital CMV
jaundice hepatosplenomegaly purpura Chronic defects --> low IQ, cerebral palsy, epilepsy, deafness and eye problems
47
Tetanus
Tetanospasmin - exotoxin of Clostridium tetani | Causes muscle spasm, rigidity, cardinal features of tetanus
48
Pathogenesis of Tetanus
C. tetani spores live in soil, faeces, dust and on instruments Diabetics at increased risk Exotoxin travels up peripheral nerves and interferes with inhibitory synapses
49
Signs of Tetanus
Prodrome --> fever, malaise, headache Classic features --> trismus (lock jaw), risus sardonicus (grin), opisthonus (neck hyperextension), spasm, autonomic dysfunction
50
Differential diagnosis for tetanus
dental abscess rabies phenothiazine toxicity strychnine poisoning
51
Poor prognosis in tetanus
``` incubation <1 week trismus --> spasm in < 48hrs Neonates/elderly Post-infective Post-partum ```
52
Tetanus treatment
ITU - may need tracheostomy and ventilation - Human tetanus immunoglobulin - sedation but rousable
53
Tetanus prevention
Neonatal/ maternal vaccination Vaccinate if uncertain vaccination history, Severe wound - give vaccine and tetanus immunoglobulin
54
Necrotising Fascitis
Rapidly progressing infection of the deep fascia causing necrosis of subcutaneous tissues - intense pain over affected skin and underlying muscle Group A Beta-Haemolytic Streptococci, but often polymicrobial
55
Fournier's gangrene
necrotising fascitis localised to the scrotum and the pernieum
56
Management of nec fasc
radical debridement +/- amputation | IV abx - benzylpenicillin and clincamycin
57
Herpes zoster
varicella = chicken pox | contagious febrile illness with crops of blisters
58
Comlications of of h.zoster
purpura fulminans/ DIC (may need heparin) pneumonitis ataxia --> commoner in pregnancy and adults than children
59
H. zoster incubation
11-21 days
60
H. zoster infectivity
4 days before rash until all lesions are scabbed (~1 week)
61
Shingles
reactivation of h. zoster | pain in dermatological distribution preceding malaise and fever
62
Shingles treatment
aciclovir (SE decreased GFR, vomiting, encephalopathy, urticaria)
63
post-herpetic neuralgia
affected dermatomes can last years- try amitriptyline, topical lidocaine
64
Genital Herpes
flu-like prodrome grouped vesicles/papules develop around genitals, anus or throat pupules burst and form shallow ulcers --> give anti-virals (aciclovir)
65
herpes simplex encephalitis
spreads from cranial nerve ganglia to frontal and temporal lobes - Fever - Fits
66
Osteomyelitis | - causative organisms
staphylococcus aureus psuedomonas e. coli streptococci others: salmonella (sickle cell) mycobacteria funghi
67
osteomyelitis categorisation
acute haematogenous secondary to contiguous local infection (+/- vascular disease) direct inoculation from trauma/ surgery
68
Clinical features of osteomyelitis
cancellous bone - vertebrae (IVDU) and feet (DM) in children - vascular bones (long bone metaphyses- distal femur/ upper tibia) Infection leads to cortex erosion (cloacae) exudation of pus lifts up periosteum and disrupts blood supply to underlying bone --> necrosis
69
Signs and symptoms of osteomyelitits
pain of gradual onset unwillingness to move tenderness, warmth, erythema and slight effusion in neighbouring joints
70
HIV facts
retrovrius - binds via gp120 to CD4 receptors on t-lymphocytes, monocytes, macrophages and neural cells - CD4 +ve cells migrate to the lymphoid tissue where the virus replicates - infection progresses --> depletion or impaired function of CD4 +ve cells and decreasing immune function
71
HIV virology
9 subtypes (clades) viral reverse transcriptase makes a DNA copy of the RNA genome -viral integrase integrates this into the host DNA - viral protease cuts up polypeptide blocks - completed virions are released by budding
72
HIV seroconversion
primary infection - accompanied by transient illness 2-6 weeks after infection - fever, malaise, myalgia, pharyngitis, maculopapular rash or meningoencephalitis - followed by asymptomatic infection (30% have persistent generalised lymphadenopathy)
73
Persistent generalised lymphadenopathy
nodes >1cm diameter at >/ extra-inguinal sites for 3+ months
74
Later constitutional symptoms of HIV AIDS-related Complex Prodrome to AIDS
``` Temp Night sweats Diarrhoea Weight loss +/- minor opportunistic infections - oral candida, oral hairy leukoplakia, herpes zoster, seborrhoeic dermatitis, tinea ```
75
AIDS
HIV + indicator disease e.g. TB, pnuemocystis jiroveci, aspergillosis, cryptococcus, histoplasma Kaposi's sarcoma, lymphoma, lymphoid interstitial pneuomonitis CMV- retinitis/pneunomitis Toxoplasmosis Candida Chronic HIV-associated neurocognitive diseorder
76
HIV diagnosis
- serum/salivary HIV-Ab by ELISA (may be -ve 1-3 weeks post exposure) - HIV RNA or core p24 antigen in plasma
77
HIV prevention
blood screening disposable equipment antenatal anti-retrovirals if HIV +ve +/- C-section +/- bottle feeding
78
Anti-retrovirals Protease inhibitors
slow cell-to-cell spread and lengthen the time to the first clinical event often given with low-dose ritonavir metabolised by cytochrome p450 so increases concentrations of certain drugs by competitive inhibition of their metabolism can cause dyslipidaemia, hyperglycaemia/ insulin resistance
79
Non-nucleoside reverse transcriptase inhibitors
may also interact with drugs metabolised
80
Non-nucleoside reverse transcriptase inhibitors
may also interact with drugs metabolised by cytochrome p450
81
Integrase strand transfer inhibitors | InSTIs
SE: GI upset, insomnia | maybe combined with tenofovir lamivudine
82
CCR% antagonists
CC-chemokine recepotr 5
83
Egs of HAART regime
efavirenz (NNRTI) + 2 NRTIs Monitor U&Es use at least 3 agents to reduce resistance
84
TB Diagnosis (latent)
Mantoux test | Interferon- gamma testing (Quantiferon or T-spot TB)
85
TB Diagnosis (active) (pulmonary)
``` sputum sample (3+) for MC&S for acid fast bacilli Zeihl Neelsen May need bronchoscopy and lavage ```
86
TB diagnosis (active) (non-pulmonary)
sputum/ pleura/ pleural fluid/ urine/ pus /ascites/ peritoneal/ bone marrow or CSF samples for culture CXR Incubate samples for 12 weeks on Lowenstein-Jensen medium
87
TB diagnosis (further tests
PCR- look for rifampicin resistance Histology - caseating granuloma CXR - consolidation, cavitation, fibrosis and calcification
88
Immunological evidence of TB
Tuberculin skin test - indicates immunity- previous exposure, BCG. False negatives in immunospupression
89
Treating pulmonary TB
- test colour vision (Ishihara test) (ethanbutmbutol may cause reversible ocular toxicity) - inital phase 8 weeks: Rifampicin, Isoniazid, Pryazinamide, ethambutol - Continuation phase 16 weeks: rifampicin and isoniazid. Continue pyridoxine - Consider steroids if meningeal or pericardial TB
90
TB treatment SE Rifampicin
``` - raised LFTs, stop if bilirubin increases, decreased platelets, orange discolouration, inactivation of the Pill, flu symptoms. ```
91
TB treatment SE Isoniazid
- raised LFTs - low WCC - stop if neuropathy and give pyridoxine
92
TB treatment SE Ethambutaol
Optic neuritis (colour vision first to deteriorate)
93
TB treatment SE | Pyrazinamide
heptatitis | arthralgia (CI acute gout or porphyria)
94
Chemoprophylaxis for asymptomatic TB
one or two anti-TB drugs for 3 or 6 months adults with documented recent tuberculin convrsion and some young immigrants with t-spot TB /mantoux +ve
95
Clinical features TB Pulmonary
- silent - cough - sputum - malaise - weight loss - night sweats - pleurisy - haemoptysis - pleural effusion - super-imposed pulmonary infection
96
Clinical features TB Miliary
``` haematogenous dissemination may be non-specific or overwhelming -CXR - may be retinal TB Biopsy - lung/liver/lymph nodes or marrow ```
97
Clinical features TB Genitourinary
-dysuria - frequency - loin/ back pain - haematuria - sterile pyuria Renal TB may spread to bladder, seminal vesicles, epididymis or fallopian tubes
98
Clinical features TB Peritoneal
Abdominal pain GI upset Ascites may need laparotomy
99
Clinical features TB Bone
vertebral collapse Potts vertebrae
100
Clinical features TB Skin
lupus vulgaris | jelly like nodules
101
Clinical features TB | Acute TB pericarditis
exudative allergy lesion
102
Clinical features TB Chronic pericardial effusion and constrictive pericarditis
- fibrosis/ calcification - may spread to myocardium - steroids for 11 weeksk
103
Clinical features TB Meningitis Prodrome
``` 30% mortality - fever - headache - vomiting - abdo pain - drowsiness meningism - delirium worsening over weeks +/- seizures ```
104
Clinical features TB Meningitis CNS signs
tremor papilloedema cranial nerve palsies
105
Clinical features TB Meningitis Diagnosis
LP TB PCR MRI + enhancement
106
Cholera | cause
vibrio cholerae gram negative curved flagellated motile vibrating rod
107
Cholera INcubation
hours to days
108
Cholera Spread
faecal-oral
109
Cholera | Signs
Profuse, watery 'Rice-water' Stools fever vomiting rapid dehydration --> cause of death with associated metabolic acidosis
110
Cholera | Diagnosis
stool microscopy and culture
111
Cholera | Treatment
strict barrier nursing - prompt oral rehydration - IVI of 0.9% saline +KCl
112
Cholera Prevention
Education | Good hygiene & waste disposal
113
Diptheria
Corynebacterium diphtheriae toxin Signs: tonsillitis +/- pseudomembrane over the fauces +/- lymphadenopathy Rx- erthyromycin
114
Thrush (candida albicans)
discharge described as white curds Vulva & vagina - red, fissuredand sore RF: pregnancy, immunodeficency, DM, the Pill and abx Rx: imidazole vaginal pessary - clotrimzaole
115
Malaria biology
Plasmodium protozoa injected by female anopheles mosquitos multiply in RBCs --> haemolysis, RBC sequestration and cytokine release
116
Malaria fever paroxysms
synchronous release of flocks merozoites from mature schizonts 1. Shivering 2. Hot stage- T =41, flushed, dry skin, N&V, headache 3. Sweats. T falls.
117
malaria protective factors
- GDP6 deficiency - sickle cell trait - melanesian ovalocytosis (oval shaped erythrocytes) - HLA B53
118
Falciparum malaria
Mortality = 20% (higher in < 3/ pregnancy) present within 1/12 of infection plasmodium falciparum
119
Falciparum Malaria symptoms
prodromal headache Malaise myalgia anorexia before first fever paroxysm (+/- faints)
120
Falciparum Malaria signa
anaemia jaundice hepatosplenomegaly - no rash or lymphadenopathy
121
Falciparum Malaria complications
anaemia | thrombocytopenia
122
Falciparum Malaria 5 grim signs
1. decreased conciousness/ coma (cerebral malaria) 2. convulsions 3. co-exisiting chronic illness 4. Acidosis (esp. HCO3 <15) 5. Renal failure (acute tubular necrosis)
123
Falciparum Malaria Diagnosis
serial thick and thin blood films % parasitaemia Rapid stick testss FBC (anaemia/ TCP), clotting, ABG, U&E, urinalysis, blood cultures
124
Falciparum Malaria Treatment (medicines)
use different drugs to prophylaxis - most resistent to chloroquine - uncomplicated: - -> Artemether-lumefantrine - -> artesunate-amodiaaquine - -> Dihydroartemisinin-napthoquine - -> cholorquinine + doxycycline + clindamycin
125
Falciparum Malaria Treatment (other)
- tepid sponging - paracetamol - transfusion if anaemic
126
Malaria travel prophylaxis
- proguanil (low chloroquine resisitance) | - chloroquine resistance --> mefloquine, doxycyline or atovaquone + proguanil (Malarone)
127
Chloroquine SE
Headache psychosis Retinopathy (chronic use)
128
Malarone SE
Abdo pain nausea Headache Dizzinessxx
129
Rabies
rhabdovirus spread by infected animal bites | - slight risk from scratches, licks to cuts/mouth/eyes
130
Rabies patients
present 9-90 days incubation | Prodrome: headache, malaise, odd behaviour, agitation, fever and itch around bite site.
131
Furious rabies
e.g. water provoked muscle spasms accompanied by hydrophobia
132
Dumb rabies
flaccid paralysis in the bitten limb
133
UTI classification Uncomplicated
NOrmla renal tract adn function
134
UTI classification Complicated
Abnormal renal/GU tract decreased host defence (immunosuppression/ DM) urinary tract obstruction - stones/catheter/malformation
135
UTI organism
E. Coli Proteus mirabilis and klebsiella pneumoniae Staphylococcus saprophyticus
136
Acute pyelonephritis symptoms
``` high fever, rigors, vomiting loin pain tenderness oliguria (AKI) ```
137
Cystits
``` frequency Dysuria Urgency Haematuria Suprapubic pain ```
138
Prostatitis symptoms
flu-like symptoms low back ache few urinary symptoms swollen or tender prostate
139
Signs of UTI
``` fever abdominal or loin tenderness foul smelling urine occasionally --> distended bladder or enlarged prostate ```
140
Causes of sterile pyuria
``` Treated UTI <2 weeks ago Inadequately treated UTI Appendicitis Calculi, prostatitis Bladder tumour UTI with fastidious culture requirements Papillary necrosis Tubulinterstitial nephritis Polycystic kidneys Chemical cystitis ```
141
Causes of CAP
- streptococcus pneumoniae - haemophilus influenzae -mycoplasma pneumoniae (-staphylococcus aureus)
142
Causes of Hospital acquired pneumonia
commonly gram-negative enterobacteria or staph. aureus | Pseudomonas, Klebsiella, Bacteroides and clostridia
143
Causes of aspiration pneumonia
``` stroke myasthenia bulbar palsies decreased conciousness oesphageal disease poor dental hygiene ```
144
Causes of pneumonia in the immunocompromised patient
- strep pneumoniae - H. influenzae - staph. aureus - M. catarrhalis M. pneumoniae Gram -ve bacilli and pneumocystis jiroveci Fungi Viruses - CMV, HSV Mycobacteria
145
Symptoms of pneumonia
``` fever Rigors anorexia Dyspnoea cough purulent sputum Haemoptysis Pleuritic pain ```
146
Signs of Pneumonia
``` Pyrexia Cyanosis Confusion tachypnoea Tachycardia Hypotension Signs of consolidation Pleural Rub ```
147
Signs of consolidation
diminished expansion Dull percussion note Increased vocal femitus/resonance Bronchial breathing
148
Pneumonia tests
ABG CXR FBC, U&Es, LFTs, CRP, Blood cultures Sputum cultures
149
Pneumonia severity
CURB-65 - Confusion - Urea >7mmol/L - Resp rate >/ 30/min - BP <90 systolic - Age >65 0-1 --> Home 2--> hospital therapy 3> severe- mortality 15-40% consider ITU
150
Penumonia Management
``` Abx --> typically co-amoxiclav/ amoxicillian or clarythromycin or doxycyline Oxygen --> keep PaO2 >8.0 IV fluids VTE prophylaxis Analgesia if pleurisy ```
151
Complications of pneumonia
``` pleural effusion empyema lung abscess respiratory failure septicaemia brain abscess pericarditis myocarditis cholestatic jaundice ```
152
Lung abscess
cavitating area of localised, suppurative infection within the lung
153
Lung abscess causes
- inadequately treated pneumonia - aspiration - bronchial obstruction - pulmonary infarction - septic emboli - subphrenic or hepatic abscess
154
Clincial features of lung abscesses
``` swinging fever cough purulent, foul smelling sputum pleuritic chest pain, haemoptysis malaise weight loss ``` --> finger clubbing, anaemia, crepitations
155
Lung abscess tests
FBC- anaemia & neutrophilia, ESR, CRP, blood cultures Sputum microscopy and cultures and cytology CXR
156
Meningitis organisms
meningococcus or pneumococcus | Less commonly haemophilus influenzea, listeria monocytogenes, CMV, cryptococcus or TB
157
Meningitis differentials
``` malaria encephalitis septicaemia subarachnoid haemorrhage dengue tentanus ```
158
Early features of meningitis
headache leg pains cold hands and feet abnormal skin colour
159
Later features of meningitis
Meningism - neck stiffness, photophobia, Kernig's sign (pain and resistance on passive knee extension with fully flexed hips) - decreased conciousness, coma - seizures +/- focal CNS +/- opisthotonus -petechial rash Galloping sepsis - slow cap refill, DIC, low BP, temp, high or normal pulse
160
Meningitis management
start abx asap --> cefotaxime | rifampicin for close contacts or ciprofloxacin
161
Meningitis investigations
U&E, FBC, LFTs, glucose, coagulation screen Blood cultures, throat swabs, rectal swab, serology (EBV) LP- after CT or if GCS 15 with no focal neurology
162
LP results in Meningitis Bacterial
- often turbid - predominantly polymorphic cells - cell count 90-1000 - glucose - low/normal (<1/2) - protein - >1.5 - bacteria in smear and culture
163
LP results in Meningitis TB
- fibrin web - mononuclear cells - cell count - 10-1000 - <1/2 plasma glucose - protein high (1-5) - no bacteria in smear
164
LP results in Meningitis Viral
Usually clear appearance - mononuclear cells - cell count 50-1000 - glucose >1/2 plasma - low protein - no bacteria on culture